Concepedia

Josquin Moraly

JM

Statistics

Publications

5

Citations

108

H-Index

5

Active since

2022

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

Centre National de la Recherche Scientifique

Institut de Génétique Moléculaire de Montpellier

Josquin Moraly is an author at National Cancer Institute specializing in t cell biology, t cell activation, and long-term efficacy evaluation.

ORCID

Publications per year

2022–2025

5

Publications

5

CAR T-cell detection scoping review: an essential biomarker in critical need of standardization

David P Turicek, Victoria M. Giordani, Josquin Moraly et al. · Journal for ImmunoTherapy of Cancer · 2023 · 29 citations · Full text

, , +17

Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity

Taisuke Kondo, François X. P. Bourassa, Sooraj Achar et al. · Cell · 2025 · 25 citations · Full text

, , +16

A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

John A. Ligon, R. Taylor Sundby, Mary Frances Wedekind et al. · Clinical Cancer Research · 2022 · 22 citations · Full text

, , +15

Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut

Arundhoti Das, Gustavo Ulises Martinez-Ruiz, Nicolas Bouladoux et al. · Immunity · 2024 · 19 citations · Full text

, , +16

Vitamin C deficiency reveals developmental differences between neonatal and adult hematopoiesis

Ira Phadke, Marie Pouzolles, Alice Machado et al. · Frontiers in Immunology · 2022 · 13 citations · Full text

, , +17

1–5 of 5